Abstract
Purpose
Endolymphatic sac tumor (ELST) is a rare, slow-growing, and low-grade malignant tumor arising from the endolymphatic sac in the posterior petrous bone. The purpose of this study is to describe the clinical and radiologic features, and investigate the clinicoradiologic correlation of ELST.
Methods
We retrospectively reviewed the clinical, computed tomography (CT), magnetic resonance imaging (MRI), and pathologic findings of 14 patients with 15 ELSTs.
Results
Patients comprised of eight women and six men with a mean age of 42.3 years at the time of diagnosis and 35.2 years at the time of initial symptoms. The mean interval between initial symptoms and diagnosis was 84.7 months. The most frequent cochleovestibular symptom was hearing loss in 14 patients (100%); other cochleovestibular symptoms were tinnitus in eight patients (57.1%), vertigo in three patients (21.4%), and aural fullness in three patients (21.4%). Ten patients (71.4%) presented with facial paralyses and five patients (14.3%) presented lower cranial nerve deficits. CT findings revealed spiculated, stippled, or reticular high density within the tumors. The lesions involved mastoid cells, vertical facial nerve canal, semicircular canal, cochlea, tympanum, jugular foramen, internal auditory canal, or petrous apex. On the available MRI, all the eight lesions showed patchy and/or speckled hyperintensity on unenhanced T1WI. Five lesions showed flow voids on T2WI and T1WI. Three lesions had blood fluid levels within cysts.
Conclusion
CT and MRI findings of ELSTs are associated with clinical features. Imaging tests should be performed to identify ELSTs early and ensure greater potential for hearing preservation in patients with cochleovestibular symptoms.
Similar content being viewed by others
References
EI-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ et al (2017) WHO classification of tumours of the head and neck. Tumours of the ear, 4th edn. IARC Press, Lyon
Du J, Wang J, Cui Y, Zhang C, Li G, Fang J, Yue S, Xu L (2015) Clinicopathologic study of endolymphatic sac tumor (ELST) and differential diagnosis of papillary tumors located at the cerebellopontine angle. Neuropathology 35(5):410–420. https://doi.org/10.1111/neup.12200
Megerian CA, Semaan MT (2007) Evaluation and management of endolymphatic sac and duct tumors. Otolaryngol Clin N Am 40(3):463–478. https://doi.org/10.1016/j.otc.2007.03.002
Hassard AD, Boudreau SF, Cron CC (1984) Adenoma of the endolymphatic sac. J Otolaryngol 13(4):213–216
Gaffey MJ, Mills SE, Fechner RE, Intemann SR, Wick MR (1988) Aggressive papillary middle-ear tumor. A clinicopathologic entity distinct from middle-ear adenoma. Am J Surg Pathol 12(10):790–797. https://doi.org/10.1097/00000478-198810000-00009
Heffner DK (1989) Low-grade adenocarcinoma of probable endolymphatic sac origin A clinicopathologic study of 20 cases. Cancer 64(11):2292–2302. https://doi.org/10.1002/1097-0142(19891201)64:11%3c2292:AID-CNCR6%3e3.0.CO;2-%23
Li JC, Brackmann DE, Lo WWM, Carberry JN, House JW (1993) Reclassification of aggressive adenomatous mastoid neoplasms as endolymphatic sac tumors. Laryngoscope 103(12):1342–1348. https://doi.org/10.1288/00005537-199312000-00004
Lonser RR, Glenn GM, Walther MM, Chew EY, Libutti SK, Linehan WM, Oldfield EH (2003) von Hippel–Lindau disease. Lancet 361(9374):2059–2067. https://doi.org/10.1016/S0140-6736(03)13643-4
Poulsen MLM, Gimsing S, Kosteljanetz M, Moller HU, Brandt CA, Thomsen C, Bisgaard ML (2011) von Hippel–Lindau disease: surveillance strategy for endolymphatic sac tumors. Genet Med 13(12):1032–1041. https://doi.org/10.1097/GIM.0b013e31822beab1
Ganeshan D, Menias CO, Pickhardt PJ, Sandrasegaran K, Lubner MG, Ramalingam P, Bhalla S (2018) Tumors in von Hippel–Lindau syndrome: from head to toe-comprehensive state-of-the-art review. RadioGraphics 38(3):849–866. https://doi.org/10.1148/rg.2018170156
Ammirati M, Spallone A, Feghali J, Ma J, Cheatham M, Becker D (1995) The endolymphatic sac: microsurgical topographic anatomy. Neurosurgery 36(2):416–419. https://doi.org/10.1097/00006123-199502000-00028
Sajjadi H, Paparella M (2008) Meniere’s disease. Lancet 372(9636):406–414. https://doi.org/10.1016/S0140-6736(08)61161-7
Ferreira MAT, Feiz-Erfan I, Zabramski JM, Spetzler RF, Coons SW, Preul MC (2002) Endolymphatic sac tumor: unique features of two cases and review of the literature. Acta Neurochir 144(10):1047–1053. https://doi.org/10.1007/s00701-002-0969-7
Kempermann G, Neumann HPH, Volk B (1998) Endolymphatic sac tumours. Histopathology 33(1):2–10. https://doi.org/10.1046/j.1365-2559.1998.00460.x
Kupferman ME, Bigelow DC, Carpentieri DF, Bilaniuk LT, Kazahaya K (2004) Endolymphatic sac tumor in a 4-year-old boy. Otol Neurotol 25(5):782–786. https://doi.org/10.1097/00129492-200409000-00022
Devaney KO, Boschman CR, Willard SC, Ferlito A, Rinaldo A (2005) Tumours of the external ear and temporal bone. Lancet Oncol 6(6):411–420. https://doi.org/10.1016/S1470-2045(05)70208-4
Mukherji SK, Albernaz VS, Lo WWM, Gaffey MJ, Megerian CA, Feghali JG, Brook AL, Lewin JS, Lanzieri CF, Talbot JM (1997) Papillary endolymphatic sac tumors: CT, MR imaging, and angiographic findings in 20 patients. Radiology 202(3):801–808. https://doi.org/10.1148/radiology.202.3.9051037
Bausch B, Wellner U, Peyre M, Boedeker CC, Hes FJ, Anglani M, de Campos JM, Kanno H, Maher ER, Krauss T (2016) Characterization of endolymphatic sac tumors and von Hippel–Lindau disease in the international ELST registry. Head Neck 38(S1):E673–E679. https://doi.org/10.1002/hed.24067
Dornbos D, Kim HJ, Butman JA, Lonser RR (2018) Review of the neurological implications of von Hippel–Lindau disease. JAMA Neurol 75(5):620–627. https://doi.org/10.1001/jamaneurol.2017.4469
Manski TJ, Heffner DK, Glenn GM et al (1997) Endolymphatic sac tumors: a source of morbid hearing loss in von Hippel–Lindau disease. JAMA 277(18):1461–1466. https://doi.org/10.1001/jama.1997.03540420057030
Bambakidis NC, Megerian CA, Ratcheson RA (2004) Differential grading of endolymphatic sac tumor extension by virtue of von Hippel–Lindau disease status. Otol Neurotol 25(5):773–781. https://doi.org/10.1097/00129492-200409000-00021
Wick CC, Manzoor NF, Semaan MT, Megerian CA (2015) Endolymphatic sac tumors. Otolaryngol Clin N Am 48(2):317–330. https://doi.org/10.1016/j.otc.2014.12.006
Bell D, Gidley P, Levine N, Fuller GN (2011) Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): sine qua non radiology-pathology and the University of Texas MD Anderson Cancer Center experience. Ann Diagn Pathol 15(2):117–123. https://doi.org/10.1016/j.anndiagpath.2010.08.009
Friedman RA, Hoa M, Brackmann DE (2013) Surgical management of endolymphatic sac tumors. J Neurol Surg Part B Skull Base 74(1):12–19. https://doi.org/10.1055/s-0032-1329622
Butman JA, Kim HJ, Baggenstos M, Ammerman JM, Dambrosia J, Patsalides A, Patronas NJ, Oldfield EH, Lonser RR (2007) Mechanisms of morbid hearing loss associated with tumors of the endolymphatic sac in von Hippel–Lindau disease. JAMA 298(1):41–48. https://doi.org/10.1001/jama.298.1.41
Lo WW, Applegate LJ, Carberry JN, Soltibohman LG, House JW, Brackmann DE, Waluch V, Li JC (1993) Endolymphatic sac tumors: radiologic appearance. Radiology 189(1):199–204. https://doi.org/10.1148/radiology.189.1.8372194
Patel NP, Wiggins RH 3rd, Shelton C (2006) The radiologic diagnosis of endolymphatic sac tumors. Laryngoscope 116(1):40–46. https://doi.org/10.1097/01.mlg.0000185600.18456.36
Poletti AM, Dubey SP, Barbo R, Pericotti S, Fiamengo B, Colombo G, Scorsetti M, Lorusso R, Mazzoni A (2013) Sporadic endolymphatic sac tumor: its clinical, radiological, and histological features, management, and follow-up. Head Neck 35(7):1043–1047. https://doi.org/10.1002/hed.22962
Mendenhall WM, Suárez C, Skálová A, Strojan P, Triantafyllou A, Devaney KO, Williams MD, Rinaldo A, Ferlito A (2018) Current treatment of endolymphatic sac tumor of the temporal bone. Adv Ther 35(7):887–898. https://doi.org/10.1007/s12325-018-0730-0
Zanoletti E, Girasoli L, Borsetto D, Opocher G, Mazzoni A, Martini A (2017) Endolymphatic sac tumour in von Hippel–Lindau disease: management strategies. Acta Otorhinolaryngol Ital 37(5):423–429. https://doi.org/10.14639/0392-100x-1402
Jagannathan J, Butman JA, Lonser RR, Vortmeyer AO, Zalewski CK, Brewer C, Oldfield EH, Kim HJ (2007) Endolymphatic sac tumor demonstrated by intralabyrinthine hemorrhage. J Neurosurg 107(2):421–425. https://doi.org/10.3171/jns-07/08/0421
Janse van Rensburg P, van der Meer G (2008) Magnetic resonance and computed tomography imaging of a grade IV papillary endolymphatic sac tumour. J Neurooncol 89(2):199–203. https://doi.org/10.1007/s11060-008-9605-6
Schipper J, Maier W, Rosahl SK, van Velthoven V, Berlis A, Boedeker CC, Laszig R, Teszler CB, Ridder GJ (2006) Endolymphatic sac tumours: surgical management. J Otolaryngol 35(6):387–394. https://doi.org/10.2310/7070.2006.0082
Diaz RC (2011) Head and neck: ear: endolymphatic Sac Tumor (ELST). Atlas Genet Cytogenet Oncol Haematol 14(3):321–326. https://doi.org/10.4267/2042/44722
Suárez C, Sevilla MA, Llorente JL (2007) Temporal paragangliomas. Eur Arch Otorhinolaryngol 264(7):719–731. https://doi.org/10.1007/s00405-007-0267-3
Semaan MT, Wick CC, Kinder KJ, Stuyt JG, Chota RL, Megerian CA (2016) Retrosigmoid versus translabyrinthine approach to acoustic neuroma resection: a comparative cost-effectiveness analysis. Laryngoscope 126(S3):S5–S12. https://doi.org/10.1002/lary.25729
Coffey N, Torres C, Glikstein R, Al Mansoori T, del Carpio-O'Donovan R, Patro S (2017) Imaging findings in sensorineural hearing loss: a pictorial essay. Can Assoc Radiol J 68(2):106–115. https://doi.org/10.1016/j.carj.2015.12.001
Zhang F, Sha Y (2013) Computed tomography and magnetic resonance imaging findings for primary middle-ear carcinoma. J Laryngol Otol 127(6):578–583. https://doi.org/10.1017/S0022215113000923
Nevoux J, Nowak C, Vellin J, Lepajolec C, Sterkers O, Richard S, Bobin S (2014) Management of endolymphatic sac tumors: sporadic cases and von Hippel–Lindau disease. Otol Neurotol 35(5):899–904. https://doi.org/10.1097/MAO.0000000000000299
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work, there is no professional or other personal interest of any nature or kind in any product, service and/or company that could be construed as influencing the position presented in, or the review of, the manuscript entitled “Clinicoradiologic Characteristics of Endolymphatic Sac Tumors”.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Le, H., Zhang, H., Tao, W. et al. Clinicoradiologic characteristics of endolymphatic sac tumors. Eur Arch Otorhinolaryngol 276, 2705–2714 (2019). https://doi.org/10.1007/s00405-019-05511-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-019-05511-8